|
ALMS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.729600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.317200E-01 |
| Normal-vs-Stage2 |
8.136600E-01 |
| Normal-vs-Stage3 |
6.551800E-01 |
| Normal-vs-Stage4 |
8.996300E-03 |
| Stage1-vs-Stage2 |
6.955200E-01 |
| Stage1-vs-Stage3 |
7.207600E-01 |
| Stage1-vs-Stage4 |
2.175400E-01 |
| Stage2-vs-Stage3 |
9.371000E-01 |
| Stage2-vs-Stage4 |
1.918430E-01 |
| Stage3-vs-Stage4 |
1.136220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.476200E-01 |
| Normal-vs-AfricanAmerican |
1.586350E-01 |
| Normal-vs-Asian |
2.899800E-01 |
| Caucasian-vs-AfricanAmerican |
3.894400E-01 |
| Caucasian-vs-Asian |
7.165800E-01 |
| AfricanAmerican-vs-Asian |
9.007000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.719580E-02 |
| Normal-vs-Female |
4.072200E-02 |
| Male-vs-Female |
1.550190E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.278600E-01 |
| Normal-vs-Extreme_Weight |
5.242000E-02 |
| Normal-vs-Obese |
8.171600E-01 |
| Normal-vs-Extreme_Obese |
7.300400E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.357600E-01 |
| Normal_Weight-vs-Obese |
2.011600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.084400E-01 |
| Extreme_Weight-vs-Obese |
5.364300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.419200E-01 |
| Obese-vs-Extreme_Obese |
2.103000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.659600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.847200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.319700E-02 |
| Normal-vs-Age(81-100Yrs) |
7.637400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.897600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.418600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.406100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.019600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.176290E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.393200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.951800E-01 |
| Normal-VS-Type2 PRCC |
4.437600E-02 |
| Normal-VS-KIRP CIMP |
9.805800E-01 |
| Normal-VS-Unclassified PRCC |
4.030600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.201800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.955400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.716190E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.551000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.678300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.408400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.846230E-02 |
| Normal-vs-N1 |
8.629200E-01 |
| Normal-vs-N2 |
6.667600E-01 |
| N0-vs-N1 |
1.159750E-01 |
| N0-vs-N2 |
5.279800E-01 |
| N1-vs-N2 |
7.748600E-01 |
|
|
